title: Diltiazem inhibits the spontaneous platelet aggregation in essential hypertension.
abstract: Plasma beta-thromboglobulin, initial (spontaneous) and total platelet aggregation, induced by adrenaline or ADP, were determined in 15 patients with essential hypertension before and after 1 week of diltiazem therapy. Diltiazem significantly decreased the spontaneous platelet aggregation in a therapeutic dose of 3 x 60 mg/day. This antiaggregatory effect is the further advantage of the antihypertensive therapy with diltiazem that may be of importance for the inhibition of atherosclerotic and thrombotic complications in essential hypertension.
authors.affiliation: 1st Department of Internal Medicine, Faculty of Medicine, Comenius University, Bratislava, Czechoslovakia.
authors.forename: J
authors.initials: J
authors.lastname: Pechán
authors.forename: A
authors.initials: A
authors.lastname: Okrucká
mesh_terms: D000328:Adult; D004110:Diltiazem / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D001620:beta-Thromboglobulin / Q000378:metabolism
chemical_list: D010975:Platelet Aggregation Inhibitors; D001620:beta-Thromboglobulin; D004110:Diltiazem